(DRN) Direxion Daily Real Estate - Overview
Etf: ETF, Swap, REIT, Leverage, Index
Dividends
| Dividend Yield | 2.48% |
| Yield on Cost 5y | 1.89% |
| Yield CAGR 5y | -34.28% |
| Payout Consistency | 50.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.3% |
| Relative Tail Risk | 1.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -30.66 |
| Character TTM | |
|---|---|
| Beta | 1.576 |
| Beta Downside | 1.840 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.59% |
| CAGR/Max DD | -0.11 |
Description: DRN Direxion Daily Real Estate December 22, 2025
Direxion Daily Real Estate Bull 3X Shares (NYSE ARCA: DRN) seeks to deliver **three times the daily performance** of the Dow Jones U.S. Real Estate Index by using swaps, futures, and other derivatives; at least 80 % of its net assets are allocated to these leveraged instruments.
The underlying index is composed of **real-estate management, development firms, and REITs that exclude mortgage REITs**, making the fund **non-diversified** and heavily weighted toward the U.S. commercial-property sector.
Key metrics (as of the most recent filing): an **expense ratio of 0.95 %**, **average daily trading volume of roughly 10 million shares**, and a **beta of ~3.0** relative to the index, reflecting the intended 3× exposure but also amplifying daily compounding risk.
Real-estate equities are especially sensitive to **interest-rate movements** (which affect REIT financing costs and cap-rate compression) and **macro-economic indicators** such as GDP growth and employment trends that drive demand for office, retail, and industrial space.
Because the leverage is reset **daily**, the fund’s long-term return can diverge significantly from three times the index’s cumulative performance, particularly in volatile markets-a risk that investors should model explicitly before allocating capital.
For a deeper, data-driven look at DRN’s risk-adjusted performance and scenario analysis, check out the ValueRay research page.
What is the price of DRN shares?
Over the past week, the price has changed by +9.11%, over one month by +11.53%, over three months by +6.96% and over the past year by -7.35%.
Is DRN a buy, sell or hold?
What are the forecasts/targets for the DRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.4 | -2% |
DRN Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 53.1m USD (53.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 53.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 53.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 11.72% (E(53.1m)/V(53.1m) * Re(11.72%) + (debt-free company))
Discount Rate = 11.72% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)